High-resolution mapping of DNA methylation in human genome using oligonucleotide tiling array
暂无分享,去创建一个
Shuichi Tsutsumi | Hiroyuki Aburatani | H. Aburatani | A. Kaneda | G. Nagae | T. Kozaki | S. Tsutsumi | Hiroshi Hayashi | Genta Nagae | Hiroshi Hayashi | Kiyofumi Kaneshiro | Takazumi Kozaki | Atsushi Kaneda | Hajime Sugisaki | H. Sugisaki | K. Kaneshiro | Kiyofumi Kaneshiro
[1] Hiroyuki Aburatani,et al. Allelic dosage analysis with genotyping microarrays. , 2005, Biochemical and biophysical research communications.
[2] M. Groudine,et al. Genomic Targeting of Methylated DNA: Influence of Methylation on Transcription, Replication, Chromatin Structure, and Histone Acetylation , 2000, Molecular and Cellular Biology.
[3] S. H. Munroe,et al. Diversity of antisense regulation in eukaryotes: Multiple mechanisms, emerging patterns , 2004, Journal of cellular biochemistry.
[4] Wei Dong Chen,et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.
[5] M. Widschwendter,et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? , 2004, The Lancet.
[6] Antony V. Cox,et al. DNA Methylation Profiling of the Human Major Histocompatibility Complex: A Pilot Study for the Human Epigenome Project , 2004, PLoS biology.
[7] Hiroki Nagase,et al. Association of tissue-specific differentially methylated regions (TDMs) with differential gene expression. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] A. Kaneda,et al. Reduced expression of the insulin‐induced protein 1 and p41 Arp2/3 complex genes in human gastric cancers , 2002, International journal of cancer.
[9] Jingde Zhu,et al. Methylation profile of the promoter CpG islands of 14 "drug-resistance" genes in hepatocellular carcinoma. , 2004, World journal of gastroenterology.
[10] Michael Q. Zhang,et al. Large-scale structure of genomic methylation patterns. , 2005, Genome research.
[11] Y. Hosoya,et al. Establishment of methylation-sensitive-representational difference analysis and isolation of hypo- and hypermethylated genomic fragments in mouse liver tumors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[12] A. Bird. DNA methylation patterns and epigenetic memory. , 2002, Genes & development.
[13] J. Herman,et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. , 2000, Cancer research.
[14] Axel Meyer,et al. Evolutionary conservation of regulatory elements in vertebrate Hox gene clusters. , 2003, Genome research.
[15] M. Ehrlich,et al. DNA methylation in cancer: too much, but also too little , 2002, Oncogene.
[16] S. P. Fodor,et al. Large-Scale Transcriptional Activity in Chromosomes 21 and 22 , 2002, Science.
[17] W. Lam,et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells , 2005, Nature Genetics.
[18] H. Aburatani,et al. Genomic approach for the understanding of dynamic aspect of chromosome behavior. , 2006, Methods in enzymology.
[19] Mark Groudine,et al. Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells , 2004, Nature Structural &Molecular Biology.
[20] A. Sakurada,et al. Genome-wide profiling of promoter methylation in human , 2006, Oncogene.
[21] M. Widschwendter,et al. DNA Methylation in Serum and Tumors of Cervical Cancer Patients , 2004, Clinical Cancer Research.
[22] M. Frydenberg,et al. Hypermethylation of the Inhibin α-Subunit Gene in Prostate Carcinoma , 2002 .
[23] Manel Esteller,et al. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells. , 2004, Human molecular genetics.
[24] Peter A. Jones,et al. The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.
[25] S. Schreiber,et al. Development and validation of a T7 based linear amplification for genomic DNA , 2003, BMC Genomics.
[26] R. Myers,et al. genome Direct isolation and identification of promoters in the human data , 2005 .
[27] A. Feinberg,et al. The epigenetic progenitor origin of human cancer , 2006, Nature Reviews Genetics.
[28] Erez Y. Levanon,et al. Widespread occurrence of antisense transcription in the human genome , 2003, Nature Biotechnology.
[29] L. Poon,et al. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. , 2002, Clinical chemistry.
[30] Rachel Jones,et al. Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Genetics.
[31] Rachel Jones,et al. Behavioural genetics: Worms gang up on bacteria , 2002, Nature Reviews Neuroscience.
[32] M. Frommer,et al. CpG islands in vertebrate genomes. , 1987, Journal of molecular biology.
[33] S. Cawley,et al. Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.
[34] Jun Kawai,et al. Restriction landmark genomic scanning method and its various applications , 1993, Electrophoresis.
[35] S. Cawley,et al. Novel RNAs identified from an in-depth analysis of the transcriptome of human chromosomes 21 and 22. , 2004, Genome research.
[36] Paul T. Groth,et al. The ENCODE (ENCyclopedia Of DNA Elements) Project , 2004, Science.
[37] C. Tabin,et al. Early developmental arrest of mammalian limbs lacking HoxA/HoxD gene function , 2005, Nature.
[38] Jan Komorowski,et al. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. , 2005, Human molecular genetics.
[39] Peter A. Jones,et al. A blueprint for a Human Epigenome Project: the AACR Human Epigenome Workshop. , 2005, Cancer research.
[40] Xiangdong Fang,et al. Locus control regions. , 2002, Blood.
[41] R. Myers,et al. Comprehensive analysis of transcriptional promoter structure and function in 1% of the human genome. , 2005, Genome research.
[42] Michael J. Terry,et al. HOX gene clusters are hotspots of de novo methylation in CpG islands of human lung adenocarcinomas , 2002, Oncogene.
[43] Terence P. Speed,et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias , 2003, Bioinform..
[44] Daiya Takai,et al. Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] T. Huang,et al. Methylation profiling of CpG islands in human breast cancer cells. , 1999, Human molecular genetics.
[46] S. Cawley,et al. Transcriptome of Human Chromosomes 21 and 22 Novel RNAs Identified From an In-Depth Analysis of the data , 2004 .
[47] Martin Widschwendter,et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. , 2005, Cancer research.
[48] Eric S. Lander,et al. Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse , 2005, Cell.
[49] M. Tsao,et al. Identification of 27 5′ CpG islands aberrantly methylated and 13 genes silenced in human pancreatic cancers , 2004, Oncogene.
[50] Christoph Grunau,et al. Identification and resolution of artifacts in bisulfite sequencing. , 2002, Methods.
[51] J. F. Schmitt,et al. Hypermethylation of the inhibin alpha-subunit gene in prostate carcinoma. , 2002, Molecular endocrinology.